|
Additional information: the device was not available; therefore, product testing on the actual device could not be performed.The device history record review of the manufacturing lot was performed and there were no non-conformities found to be related to the reported event.A review of the device labeling was completed.Elevated iop is identified in the labeling as a known inherent risk of trabecular micro-bypass aqueous shunt procedure.The ifu adequately provides instructions for stent implantation, precautions, and warnings for the proper use and handling of the device.An adverse event appears to have occurred, but does not appear to have been a problem with the device or the way it was used.Elevated iop is an established risk associated with use of the device, which is clearly specified in the product''s labeling.Based on the information received, the root cause of the reported event could not be conclusively identified.Mfr# reference: (b)(4).
|
|
It was reported that following a right eye (od) trabecular microbypass system procedure, the patient presented approximately three (3) months postop with a "non serious" intraocular pressure (iop) increase described as "iop over target", which was treated with medication.Additional information has been requested.
|